| Product Code: ETC13149569 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Middle East Neurodegenerative Disease Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East Neurodegenerative Disease Treatment Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East Neurodegenerative Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Middle East Neurodegenerative Disease Treatment Market - Industry Life Cycle |
3.4 Middle East Neurodegenerative Disease Treatment Market - Porter's Five Forces |
3.5 Middle East Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Middle East Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Middle East Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
3.8 Middle East Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Route of Administration:, 2021 & 2031F |
3.9 Middle East Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Distribution Channel:, 2021 & 2031F |
4 Middle East Neurodegenerative Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East Neurodegenerative Disease Treatment Market Trends |
6 Middle East Neurodegenerative Disease Treatment Market, 2021 - 2031 |
6.1 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Multiple Sclerosis, 2021 - 2031 |
6.1.3 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Parkinson's Disease, 2021 - 2031 |
6.1.4 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Alzheimer's Disease, 2021 - 2031 |
6.1.5 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Spinal Muscular Atrophy (SMA), 2021 - 2031 |
6.1.6 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Huntington's Disease, 2021 - 2031 |
6.1.7 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Drug Type:, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021 - 2031 |
6.2.3 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021 - 2031 |
6.2.4 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Dopamine Inhibitors, 2021 - 2031 |
6.2.5 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.3.4 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.4.3 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.4.4 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Middle East Neurodegenerative Disease Treatment Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.1 Saudi Arabia Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.2 UAE Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.3 Kuwait Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.4 Qatar Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.5 Bahrain Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.6 Oman Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.7 Turkey Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.8 Rest of Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3 Middle East Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
7.3.1 Saudi Arabia Neurodegenerative Disease Treatment Market, Revenues & Volume, By Drug Type:, 2021 - 2031 |
7.3.2 UAE Neurodegenerative Disease Treatment Market, Revenues & Volume, By Drug Type:, 2021 - 2031 |
7.3.3 Kuwait Neurodegenerative Disease Treatment Market, Revenues & Volume, By Drug Type:, 2021 - 2031 |
7.3.4 Qatar Neurodegenerative Disease Treatment Market, Revenues & Volume, By Drug Type:, 2021 - 2031 |
7.3.5 Bahrain Neurodegenerative Disease Treatment Market, Revenues & Volume, By Drug Type:, 2021 - 2031 |
7.3.6 Oman Neurodegenerative Disease Treatment Market, Revenues & Volume, By Drug Type:, 2021 - 2031 |
7.3.7 Turkey Neurodegenerative Disease Treatment Market, Revenues & Volume, By Drug Type:, 2021 - 2031 |
7.3.8 Rest of Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Drug Type:, 2021 - 2031 |
7.4 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
7.4.1 Saudi Arabia Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
7.4.2 UAE Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
7.4.3 Kuwait Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
7.4.4 Qatar Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
7.4.5 Bahrain Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
7.4.6 Oman Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
7.4.7 Turkey Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
7.4.8 Rest of Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Route of Administration:, 2021 - 2031 |
7.5 Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
7.5.1 Saudi Arabia Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
7.5.2 UAE Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
7.5.3 Kuwait Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
7.5.4 Qatar Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
7.5.5 Bahrain Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
7.5.6 Oman Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
7.5.7 Turkey Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
7.5.8 Rest of Middle East Neurodegenerative Disease Treatment Market, Revenues & Volume, By Distribution Channel:, 2021 - 2031 |
8 Middle East Neurodegenerative Disease Treatment Market Key Performance Indicators |
9 Middle East Neurodegenerative Disease Treatment Market - Export/Import By Countries Assessment |
10 Middle East Neurodegenerative Disease Treatment Market - Opportunity Assessment |
10.1 Middle East Neurodegenerative Disease Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Middle East Neurodegenerative Disease Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
10.3 Middle East Neurodegenerative Disease Treatment Market Opportunity Assessment, By Drug Type:, 2021 & 2031F |
10.4 Middle East Neurodegenerative Disease Treatment Market Opportunity Assessment, By Route of Administration:, 2021 & 2031F |
10.5 Middle East Neurodegenerative Disease Treatment Market Opportunity Assessment, By Distribution Channel:, 2021 & 2031F |
11 Middle East Neurodegenerative Disease Treatment Market - Competitive Landscape |
11.1 Middle East Neurodegenerative Disease Treatment Market Revenue Share, By Companies, 2022 |
11.2 Middle East Neurodegenerative Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here